| Biomarker ID | 1728 |
| PMID | 30516927 |
| Year | 2018 |
| Biomarker | HA: Hyaluronic acid |
| Biomarker Basis | Concentration Based (μg/mL) |
| Biomolecule | Metabolites |
| Source | Serum |
| Subjects | Humans |
| Regulation | Upregulated in Patient Reclassification |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | NA |
| Experiment | Before and After Surgery Levels |
| Type of Biomarker | Predictive |
| Cohort | 44 prostate cancer patients and 14 controls were used in this analysis. Cancer patients were treated with open or laparoscopic radical prostatectomy (32 patients) |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p=0.029 |
| Method Used | fluorescence-based ELISA like assay |
| Clinical | No |
| Remarks | Cancer patients were trea- ted with open or laparoscopic radical prostatec- tomy (32 patients |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |